Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Racial Impacts of COVID-19, Neutralizing Antibodies, More

    Aug 28, 2020, 10:05 AM by Michael Croft

    Bio-IT World | Racial segregation of COVID-19 is following HIV patterns, more data on neutralizing antibodies, four months of data from Italy's use of hydroxychloroquine, and a computer model for school launches. Plus, an award from the UK government for vaccine development. 

    Full story
  • CD Genomics Introduces Extended Panels for SARS-CoV-2 Detection and Research

    Aug 28, 2020, 01:42 AM by Michael Croft
    SHIRLEY, NY, UNITED STATES - Aug 28, 2020 - CD Genomics, a leader in sequencing, microarray analysis, library construction and genotyping, recently announced availability of its CDAMP® SARS-CoV-2 Panel Kit, CDCAP® β-CoVs Panel Kit and CDCAP® Respiratory Virus Panel Kit for SARS-CoV-2 detection and research via its predesigend NGS panels
    Full story
  • UK Biobank Contracts With DNAnexus, AWS to Build Data Analysis Platform

    Aug 26, 2020, 14:40 PM by Michael Croft
    Bio-IT World  UK Biobank, a long-term study of health data from 500,000 UK volunteers, announced today that it is developing its own cloud-based Data Analysis Platform to make its extensive medical data available to a broader range of researchers around the world. Funding for the Data Analysis Platform has come from Wellcome, and it will be developed over the next three years by DNAnexus in collaboration with Amazon Web Services (AWS).
    Full story
  • Panthera further extends its network of clinical trial sites with the opening of a clinical trial site in North London in collaboration with Medicus Health Partners

    Aug 26, 2020, 10:49 AM by Michael Croft
    PRESTON, UNITED KINGDOM - Aug 26, 2020 - Since launching its first site in Preston in North West England in 2019, Panthera continues to expand its network of UK clinical trial sites with a new site in North London in collaboration with a GP Super partnership Medicus Health Partners
    Full story
  • Vertiv, Pure Storage, And More: News From August 2020

    Aug 25, 2020, 15:15 PM by Michael Croft
    Bio-IT World   August featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Vertiv, Pure Storage, and more.
    Full story
  • Aveshka announces Dr. Til Jolly as Chief Medical Officer

    Aug 21, 2020, 21:24 PM by Michael Croft
    WASHINGTON, DC, UNITED STATES - Aug 10, 2020 - Aveshka announced Dr. Til Jolly will join the company’s executive team in the newly created role of Chief Medical Officer (CMO)
    Full story
  • Beetle Viruses, Nitrate Supplements, Missing Sense of Smell: COVID-19 Updates

    Aug 21, 2020, 09:35 AM by Michael Croft
    Bio-IT World | How a beetle virus is informing SARS-CoV-2 research, plus nitrate supplementation for aid breathing, new small molecules active against the virus, and a theory for why COVID-19 patients lose their sense of smell. Plus, $9.8 million from DOD for vaccine research and virus-like particles for vaccine development.
    Full story
  • The Chemistry-Focused Technology Platform Is Optimized at Alfa Chemistry

    Aug 20, 2020, 23:49 PM by Michael Croft
    NY, NY - Aug 19, 2020 - Alfa Chemistry, the US-located chemical supplier, has recently announced that it has finished the optimization work of its chemistry-focused technology platform, which enables the company to offer a comprehensive range of services such as synthetic chemistry, chiral separations, small molecule synthesis, peptide, nucleoside, fluorinated building blocks, milligram preparation, kilogram GLP scale-up, reagent service, and compound management
    Full story
  • AI & Medicine Develops Medical Therapy and Research System to Facilitate Disease Treatment

    Aug 20, 2020, 23:36 PM by Michael Croft
    NY, NY - Aug 20, 2020 - AI & Medicine, one of the forerunners in the AI-assisted medicine area, announces that it has successfully developed a medical therapy and research system, which can assist in disease treatment, health management, adjuvant therapy, and deep mining of public document database
    Full story
  • InSysBio to present the new version of Immune Response Template

    Aug 20, 2020, 10:41 AM by Michael Croft
    MOSCOW, RUSSIA - Aug 20, 2020 - InSysBio, one of the world’s pioneers of Quantitative Systems Pharmacology (QSP) modeling, presents the new version of its Immune Response Template (IRT)
    Full story
  • Combined Monogenic, Polygenic Risk Scores Could Change Medical Understanding of Disease

    Aug 20, 2020, 08:20 AM by User Not Found
    Bio-IT World | In a paper published today in Nature Communications, IBM and the Broad Institute reported the first results of their collaboration to develop predictive models for cardiovascular disease.
    Full story
  • Rho Experts Share Approach for Maximizing Benefits of Decentralized Trials During Free Webinar

    Aug 19, 2020, 16:53 PM by Michael Croft
    DURHAM, NC, US - Aug 20, 2020 - MEDIA ADVISORYRho Experts Share Approach for Maximizing Benefits of Decentralized Trials During Free WebinarCRO shares best practices and solutions to help sponsors get the most out of their hybrid, virtual and synthetic clinical trials  WHAT:                 Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, will discuss its approach to and solutions for maximizing the benefits of decentralized clinical trials in an upcoming webinar, "CROs: The Tip of the Spear in Maximizing the Value of Hybrid, Virtual, and Synthetic Clinical Trials
    Full story
  • Lyniate and PatientPing Form Strategic Partnership to Ensure Compliance with the CMS E-Notifications Requirements

    Aug 19, 2020, 09:14 AM by Michael Croft
    BOSTON, MA - Aug 19, 2020 - Lyniate, a global leader in healthcare data interoperability, today announced a partnership with PatientPing, the nation’s most comprehensive care collaboration platform, to develop a connector solution that provides the IT infrastructure necessary to support seamless integration of e-notification data for admissions, discharges, and transfers (ADT)
    Full story
  • Ojai Valley Community Hospital Implements eVideon Solution to Support Patient Engagement Initiative

    Aug 18, 2020, 12:38 PM by Michael Croft
    GRAND RAPIDS, MI - Aug 18, 2020 - eVideon, a leader in interactive patient engagement and digital workflow solutions, today announced that Ojai Valley Community Hospital’s Continuing Care Center, a brand new 75-bed skilled nursing facility, has gone live with the company’s market-leading Patient  Experience Platform and Digital Signage  solutions
    Full story
  • Alveo Technologies Expands Leadership Team with Appointment of Julianne Averill as Chief Financial Officer

    Aug 18, 2020, 10:21 AM by Michael Croft
    ALAMEDA, CA, UNITED STATES - Aug 18, 2020 - Alveo Technologies, a leader in developing novel technologies that enable real-time, low-cost, at-home molecular detection of infectious disease, today announced it has appointed Julianne Averill, CPA, as Chief Financial Officer
    Full story
  • Absolute Antibody Offers SARS-CoV-2 Neutralizing Antibodies Derived from COVID-19 Patients

    Aug 18, 2020, 09:46 AM by Michael Croft
    REDCAR, UNITED KINGDOM - Aug 18, 2020 - Absolute Antibody Ltd., an industry-leading provider of recombinant antibody products and services, today announced the availability of SARS-CoV-2 neutralizing antibodies derived from individuals infected with COVID-19
    Full story
  • Kyruus Launches Online Consumer Scheduling for Virtual Care Visits

    Aug 18, 2020, 09:40 AM by Michael Croft
    BOSTON, MA, UNITED STATES - Aug 18, 2020 - Kyruus, the leader in provider search and scheduling solutions for health systems, today announced the availability of online scheduling for virtual care visits within its Kyruus ProviderMatch® for Consumers solution for health system websites
    Full story
  • Bringing Peer Review To Early COVID-19 Research, More News

    Aug 18, 2020, 08:35 AM by Michael Croft

    Bio-IT World | New insights into the SARS-CoV-2 spike protein, a daily aerosol protectant, a look a death rates in 1918 and now, and a journal dedicated to publishing COVID-19 research with visible peer review. Plus new funding from NIH and the American Heart Association to enable further research on SARS-CoV-2 and COVID-19.

    Full story
  • Bringing Peer Review To Early COVID-19 Research, More

    Aug 18, 2020, 08:33 AM by User Not Found
    Bio-IT World | New insights into the SARS-CoV-2 spike protein, a daily aerosol protectant, a look a death rates in 1918 and now, and a journal dedicated to publishing COVID-19 research with visible peer review. Plus new funding from NIH and the American Heart Association to enable further research on SARS-CoV-2 and COVID-19.
    Full story
  • Abzena appoints Anu Bansal Ph.D. as Senior Director of Manufacturing at Bristol, Pennsylvania facility

    Aug 18, 2020, 06:57 AM by Michael Croft
    BRISTOL, PA - Aug 18, 2020 - Cambridge, UK and San Diego, CA, 18 August 2020 - Abzena, a leading Partner Research Organization (PRO) for biopharmaceutical outsourced solutions from concept to clinic and into GMP manufacturing has announced the appointment of Anu Bansal as Senior Director of Manufacturing at its facility in Bristol, Pennsylvania
    Full story
  • «
  • 211
  • 212 (current)
  • 213
  • 214
  • 215
  • 216
  • 217
  • 218
  • 219
  • 220
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy